<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>ESRC Centre for Scocial and Economic asp</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8E5B98A2-37CC-4ACF-847D-F2D94974B3ED"><gtr:id>8E5B98A2-37CC-4ACF-847D-F2D94974B3ED</gtr:id><gtr:firstName>Ingrid</gtr:firstName><gtr:otherNames>Marije</gtr:otherNames><gtr:surname>Geesink</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=PTA-037-27-0079"><gtr:id>4FC46E50-C00A-4D42-8AC6-8182444CC009</gtr:id><gtr:title>Tissue Engineering: Risk, Regulation and Evidence of an Innovative Technology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>PTA-037-27-0079</gtr:grantReference><gtr:abstractText>&lt;p>Tissue engineering is an emerging biomedical innovation surrounded by potentiality and risk. Based on documentary analysis and expert interviews, this postdoctoral fellowship builds upon PhD research, discussing constructions of risk according to main constituencies (scientists, clinicians, manufacturers), the way they prioritise and balance these risks, and how issues are framed as problematic or not. Complexity and uncertainty are the main drivers in this exercise, interpreted in terms of boundary drawing around contested risk domains. This is followed by a discussion of the translation of risk into regulatory policy, by focusing on two recent legislative initiatives by the European Commission: one to control the quality and safety aspects of human tissues and cells (DG SANCO Directive, effective from April 2006) and the other to facilitate the marketing of tissue engineered products in the EU (DG Enterprise Regulation (EC) No 1394/2007 from November 2007). These two legislative initiatives aim to overcome the current regulatory lag in Europe, where tissue engineered applications are either unregulated or subject to a broad variety in national controls.&lt;br />&lt;/p></gtr:abstractText><gtr:fund><gtr:end>2008-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/924BE15C-91F2-4AAD-941A-3F338324B6AE"><gtr:id>924BE15C-91F2-4AAD-941A-3F338324B6AE</gtr:id><gtr:name>ESRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>65115</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4CA45AEA-AB3F-48CD-BEDC-93736B0AB513</gtr:id><gtr:title>Culturing Cells, Reproducing and Regulating the Self</gtr:title><gtr:parentPublicationTitle>Body &amp; Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7e0410e71ae90c7faf15a173ae25637"><gtr:id>c7e0410e71ae90c7faf15a173ae25637</gtr:id><gtr:otherNames>Kent J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>doi_53cfbdfbd055a7f1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B26241D8-55A4-4BC3-B9C3-A7C88980E907</gtr:id><gtr:title>Towards governance of human tissue engineered technologies in Europe: Framing the case for a new regulatory regime</gtr:title><gtr:parentPublicationTitle>Technological Forecasting and Social Change</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7e0410e71ae90c7faf15a173ae25637"><gtr:id>c7e0410e71ae90c7faf15a173ae25637</gtr:id><gtr:otherNames>Kent J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>doi_53cfb3fb31aa711e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B82A8ED7-BCF5-4F9E-9244-3AD0DDD4AE68</gtr:id><gtr:title>Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technology.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecdc3156c4525cdc0c97c8392de5d0dd"><gtr:id>ecdc3156c4525cdc0c97c8392de5d0dd</gtr:id><gtr:otherNames>Faulkner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>pm_53cbf6dbf6dc01e5e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D11F9BF-7912-4058-8EE3-9526C0532779</gtr:id><gtr:title>Human tissue engineered products--drugs or devices?</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecdc3156c4525cdc0c97c8392de5d0dd"><gtr:id>ecdc3156c4525cdc0c97c8392de5d0dd</gtr:id><gtr:otherNames>Faulkner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_53cfbbfbb8bed4cf</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">PTA-037-27-0079</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>